Lower Extremity Arteriosclerosis Obliterans with Long-Segment Femoral Artery Occlusion: Advances in Treatment

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Journal of Clinical Personalized Medicine

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.12677/jcpm.2025.42242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2024cited by this paper
• One-year Outcomes of Drug-Eluting Stent Versus Drug-Coated Balloon for Femoropopliteal Artery Lesions: BEASTARS Study Results.

  2024cited by this paper
• Beyond Wires and Knives: What Can We Learn From BEST-CLI and BASIL-2?

  2023cited by this paper
• The BEST-CLI Trial: Implications of the Primary Results.

  2023cited by this paper
• Safety and efficacy of excimer laser atherectomy combined with a drug-coated balloon in de novo femoral popliteal artery disease: a retrospective study.

  2023cited by this paper
• Diet and Nutrition in Peripheral Artery Disease: A Systematic Review.

  2022cited by this paper
• Bovine pericardial patch - A good alternative in femoral angioplasty.

  2022cited by this paper
• Outcomes of Femoral Endarterectomy with Superficial Tributary Vein Patch Angioplasty.

  2022cited by this paper
• Update on the pathophysiology and medical treatment of peripheral artery disease

  2022cited by this paper
• Long-Term Safety and Efficacy of Angioplasty of Femoropopliteal Artery Disease with Drug-Coated Balloons from the AcoArt I Trial.

  2021cited by this paper
• [Basic principles and approaches to medical rehabilitation of patients with atherosclerosis obliterans of lower limb arteries].

  2021cited by this paper
• Waksman In-Stent Restenosis Classification: A mechanism-based approach to the treatment of restenosis.

  2021cited by this paper
• Short and long-term outcome after common femoral artery hybrid procedure in patients with intermittent claudication and chronic limb threatening ischemia.

  2021cited by this paper
• Current perspectives on bioresorbable scaffolds in coronary intervention and other fields

  2021cited by this paper
• Patches of different types for carotid patch angioplasty.

  2021cited by this paper
• Midterm Outcomes of Common Femoral Endarterectomy Combined with Inflow and Outflow Endovascular Treatment for Chronic Limb Threatening Ischaemia.

  2020cited by this paper
• Vessel Preparation Is Essential to Optimize Endovascular Therapy of Infrainguinal Lesions

  2020cited by this paper
• Cilostazol and peripheral artery disease-specific health status in ambulatory patients with symptomatic PAD.

  2020cited by this paper
• Safety and feasibility of transradial infrainguinal peripheral arterial disease interventions.

  2020cited by this paper
• A drug-eluting Balloon for the trEatment of coronarY bifurcatiON lesions in the side branch: a prospective multicenter ranDomized (BEYOND) clinical trial in China

  2020cited by this paper
• Long-term outcome upon treatment of calcified lesions of the lower limb using scoring angioplasty balloon (AngioSculpt™)

  2020cited by this paper
• A national study of the prevalence and risk factors associated with peripheral arterial disease from China: The China Hypertension Survey, 2012-2015.

  2019cited by this paper
• Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease.

  2019cited by this paper
• A meta‐analysis of randomized trials comparing bovine pericardium and other patch materials for carotid endarterectomy

  2018cited by this paper
• Early Experience with a New Concept of Angioplasty Nitinol-Constrained Balloon Catheter (Chocolate®) in Severely Claudicant Patients

  2018cited by this paper
• SCAI consensus guidelines for device selection in femoral‐popliteal arterial interventions

  2018cited by this paper
• A prospective, multi‐center study of the chocolate balloon in femoropopliteal peripheral artery disease: The Chocolate BAR registry

  2018cited by this paper
• Simultaneous Hybrid Operation Common Femoral Endarterectomy and Endovascular Treatment in Multilevel Peripheral Arterial Disease with Critical Limb Ischemia

  2018cited by this paper
• Bare Metal Versus Paclitaxel-Eluting Stents for Long Femoropopliteal Lesions: Prospective Cohorts Comparison Using a Propensity Score-Matched Analysis.

  2017cited by this paper
• Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency

  2017cited by this paper
• Results of Carotid Endarterectomy Using Bovine Pericardium Patch Closure, with a Review of Pertinent Literature

  2016cited by this paper
• Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease

  2015cited by this paper
• Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).

  2015cited by this paper
• Sustained Benefit at 2 Years for Covered Stents Versus Bare-Metal Stents in Long SFA Lesions: The VIASTAR Trial

  2015cited by this paper
• Technique and results of femoral bifurcation endarterectomy by eversion.

  2015cited by this paper
• Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk.

  2014cited by this paper
• Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.

  2013cited by this paper
• Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial.

  2013cited by this paper
• Classification and clinical impact of restenosis after femoropopliteal stenting.

  2012cited by this paper
• Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease: Twelve-Month Zilver PTX Randomized Study Results

  2011cited by this paper
• Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia.

  2010cited by this paper
• Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study.

  2010cited by this paper
• Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease.

  2010cited by this paper
• Iliac artery stenting combined with open femoral endarterectomy is as effective as open surgical reconstruction for severe iliac and common femoral occlusive disease.

  2010cited by this paper
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

  2007cited by this paper
• Influence of smoking on incidence and prevalence of peripheral arterial disease.

  2004cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4-year follow-up.

  1995cited by this paper
• Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.

  1987cited by this paper

• No citing papers are available for this paper.